Marvell Technology Group Ltd.
MRVL, -0.04%
shares rose 5%. Late Thursday, it reported a lower second-quarter profit but issued a better-than-expected sales forecast. See full story on Marvell.

Tiffany & Co.
TIF, +0.79%
shares rose 11%. The luxury jewelry retailer said sales trends in August are meeting its expectations, as management raised Tiffany's full-year profit forecast to a range of $1.65 to $1.75 a share, up from a previous projection of as much as $1.60. Second-quarter profit fell but beat analysts' expectations. Read more on Retail Stocks.

Trubion Pharmaceuticals Inc.
TRBN
shares soared 45% after announcing an agreement today with Facet Biotech Corp.
590024, -2.28%
for the joint worldwide development and sell its leukemia treatment, which is in early-stage development. The announcement of the agreement could garner Trubion nearly $200 million.

YRC Worldwide Inc.
YRCW, +0.21%
shares jumped 19% to $2.37 after its subsidiary YRC Inc., the largest transportation unit of YRC Worldwide, announcing expanded window delivery capabilities across all of its transportation companies, designed to help retailers avoid charge-backs when delivery windows aren't met.

Decliners

Cost Plus Inc.
CPWM
shares slumped 19% to $2.38. The home-furnishings retailer reported late Thursday a second-quarter loss of $20.7 million, or 94 cents a share, narrower than the loss of $26.6 million, or $1.21 a share, generated in the same period a year ago. Revenue fell 13% to $183.4 million in the three months ended Aug. 1 from the prior year's $210.7 million. The company also said it anticipates continued economic volatility, weak consumer demand and pressure on the furniture business in the third quarter of the current fiscal year. Read more on Cost Plus.

Immunomedics Inc.
IMMU, +0.99%
shares fell 16% to $5.77. The company announced a Phase II study of epratuzumab has shown the product was effective in treating lupus. The product is being co-developed with Belgium drugmaker UCB. See full story on drug stocks.

Novell Inc.
NOVL
shares lost 7% to $4.38. The provider of open-source software posted a slightly worse-than-expected decline in revenue for the third quarter ended July 31, as product sales of identity and security management and systems and resource management software each fell sharply for businesses. Results showed that Novell swung to a quarterly profit of $16.7 million, or 5 cents a share, from a loss of $15.1 million, or 4 cents a share, in the same period during fiscal 2008. Read more on Novell.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.